6th Virtual Clinical Trials

Event Overview
COVID Safety

Event Overview

With more clinical trials switching to fully decentralized and hybrid models, the need for a collaborative information exchange is more important than ever. At the 6th Virtual Clinical Trials Conference, hear actual case studies from current decentralized trials and discuss the future state of clinical research from top industry experts at the forefront of clinical trial designs. Explore what is working successfully and what obstacles you can avoid in data compliance, regulatory compliance and novel submission methods.

This is the industry’s leading, longest-lasting and most trusted conference on decentralized trials, offering you exclusive insights our speaking faculty hasn’t shared anywhere else! Join us in May for all-new insights on constructing and measuring endpoints, executing effective patient recruitment strategies, applying innovative technologies – and much more!

“The lessons presented actually reflected on examples of implementation and the lessons learned”

Innovation Manager – BAYER

“I wanted to understand more about where other pharma companies are in the process of building up these platforms, this exceeded my expectations”

Director, NOVO NORDISK

COVID Safety

Vaccination is mandatory to participate in a DGE in-person event. All conference delegates, speakers, sponsors, and staff must be prepared to show proof of vaccinated status upon first entering the conference space. Mask-wearing is up to each individual’s discretion. Thank you for your help in making sure this remains a safe and healthy educational networking event!

Top Reasons to Attend

Reduce the burden on patients, and therefore improve retention and reduce the trial’s overall cost
Alleviate site visits with proven hybrid approaches to accelerate timelines and allow for faster data gathering
Ensure regulatory and process improvements are implemented to reduce workload for clinical trial sites, resulting in time and cost efficiencies
Integrate effective technologies into trial design to omit the slowdown of the trial process
Enhance safety monitoring, safety producers and follow up outcomes